Use of social cognitive theory to guide a medical treatment adherence intervention

International Journal of Interdisciplinary Social Sciences

Volumn 5, Issue 7, 2010, Pages 97-107

  Chisholm Burns, Marie ^a   Spivey, Christina ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Behavioral contracting; Medical treatment adherence; Social cognitive theory

Indexed keywords

EID: 80051506740     PISSN: 18331882     EISSN: None     Source Type: Journal    
DOI: 10.18848/1833-1882/cgp/v05i07/51791     Document Type: Article

References (49)

1. Agras, S., & Werne, J. Behavior modification in anorexia nervosa: Research foundations. In: R. A. Vigersky (Ed.). Anorexia nervosa (pp. 567-583). New York: Raven Press.
2. American Society of Transplantation. (2010). Immunosuppressive drug fact sheet. Retrieved July 19, 2010 from http://www.asts.org/Tools/Download.aspx?fid= 494.
3. Bandura, A. (1986). Social foundations of thought and action: a social cognitive theory. Englewood Cliffs, NJ: Prentice-Hall.
4. Bandura, A. (1989a). Human agency in social cognitive theory. American Psychologist, 44, 1175-1184.
5. Bandura, A. (1989b). Social cognitive theory. In R. Vasta (Ed.), Annals of child development. Vol. 6. Six theories of child development (pp. 1-60). Greenwich, CT: JAI Press.
6. Bartucci, M. R. (1999). Issues in cyclosporine drug substitution: implications for patient management. [Review]. Journal of Transplant Coordination, 9, 137-142.
7. Bosch-Capblanch, X., Abba, K., Prictor, M., & Garner, P. (2007). Contracts between patients and healthcare practitioners for improving patients' adherence to treatment, prevention and health promotion activities. Cochrane Database of Systematic Reviews, Issue 2, CD004808.
8. Butler JA, Roderick P, Mullee M, Mason JC, & Peveler RC. (2004) Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation, 77, 769-776. (Pubitemid 38366989)
9. Chisholm, M. A. (2002). Issues of adherence to immunosuppressant therapy after solid-organ transplantation. Drugs, 62, 567-575. (Pubitemid 34264026)
10. Chisholm, M. A. (2004). Identification of medication-adherence barriers and strategies to increase adherence in recipients of renal transplants. Managed Care Interface, 17, 44-48. (Pubitemid 40022078)
11. Chisholm, M. A., Bagby, T. R., Di Piro, J. T., Wade, W. E., & May, J. R. (1998). Cost analysis of renal transplantation recipients' medications 1-year post transplantation: identification of strategies for pharmacist interventions. Pharmacotherapy, 18(5), 1174.
12. Chisholm, M. A., Vollenweider, L. J., Mulloy, L. L., Jagadeesan, M., Wade, W. E., Di Piro, J. T. (2000a). Direct patient care services provided by a pharmacist on a multidisciplinary renal transplant team. American Journal of Health-System Pharmacy, 57, 1994-1996.
13. Chisholm, M. A., Vollenweider, L. J., Mulloy, L. L., Jagadeesan, M., Wynn, J. J., Rogers, H. E., Wade, W. E., & Di Piro, J. T. (2000b). Renal transplant patient compliance with free immunosuppressive medications. Transplantation, 70, 1240-1244.
14. Chisholm, M. A., Mulloy, L. L., Jagadeesan, M., & Di Piro, J. T. (2001). Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clinical Transplantation, 15, 330-336. (Pubitemid 32936880)
15. Chisholm, M. A., Lance, C. E., Williamson, G. M., & Mulloy, L. L. (2005). Development and validation of an immunosuppressant therapy adherence barrier instrument. Nephrology Dialysis Transplantation, 20, 181-188. (Pubitemid 40214334)
16. Chisholm, M. A., Kwong, W. J., & Spivey, C. A. (2007). Associations of characteristics of renal transplant recipients with clinicians' perceptions of adherence to immunosuppressant therapy. Transplantation, 84, 1145-50. (Pubitemid 350125357)
17. De Geest, S., Borgermans, L., Gemoets, H., Abraham, I., Vlaminck, H., Evers, G., & Vanrenterghem, Y. (1995). Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation, 59, 340-347.
18. De Geest, S., Schöfer-Keller, P., Denhaerynck, K., Thannberger, N., Köfer, S., Bock, A., et al. (2006). Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clinical Transplantation, 20, 359-368. (Pubitemid 43880573)
19. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP. (1996). Medical compliance and its predictors in the first year after heart transplantation. Journal of Heart and Lung Transplantation, 15, 631-645. (Pubitemid 26225448)
20. Frazier, P., Davis-Ali, S., & Dahl, K. (1994). Correlates of noncompliance among renal transplant recipients. Clinical Transplantation, 8, 550-557. (Pubitemid 24361561)
21. Gaston, R., Hudson, S., War, M., Jones, R., & Macon, R. (1999). Late renal allograft loss: noncompliance masquerading as chronic rejection. Transplantation Proceedings, 31, 21s-23s. (Pubitemid 29282400)
22. Glanz, K., Rimer, B. K. & Lewis, F. M. (2002). Health Behavior and Health Education. Theory, Research and Practice. San Francisco: Wiley & Sons.
23. Gorski, J., Slifer, K., Townsend, V., Kelly-Suttka, J., & Amari, A. (2005). Behavioural treatment of non-compliance in adolescents with newly acquired spinal cord injuries. Pediatric Rehabilitation, 8, 187-198. (Pubitemid 40978681)
24. Greenstein, S., & Siegal, B. (1998). Compliance and noncompliance in patients with functioning renal transplant: a multicenter study. Transplantation, 66, 1718-1726. (Pubitemid 29034998)
25. Haber, D., & Rhodes, D. (2004). Health contract with sedentary older adults. The Gerontologist, 44, 827-835. (Pubitemid 39658459)
26. Hardstaff, R., Green, K., & Talbot D. (2003). Measurement of compliance posttransplantation - the results of a 12-month study using electronic monitoring. Transplantation Proceedings, 35, 796-797. (Pubitemid 36338163)
27. Harmon, G., Lefante, J., & Krousel-Wood, M. (2006). Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications. Current Opinions in Cardiology, 21, 310-315. (Pubitemid 44315063)
28. Hauboldt, R. A. (2007). 2007 U. S.organ and tissue transplant cost estimates. Milliman Retrieved July 19, 2010 from http://publications.milliman. com/research/health-rr/pdfs/2007-US-Organ-Transplant-RR11-01-07.pdf.
29. Hilbrands, L. B., Hoitsma, A. J., & Koene, R. A. (1995). Medication compliance after renal transplantation. Transplantation, 60, 914-920.
30. Janz, N. K., Becker, M. H., & Hartman, P. E. (1984). Contingency contracting to enhance patient compliance: a review. Patient Education and Counseling, 5, 165-178.
31. Koch, D. A., Giardina, P. J., Ryan, M., MacQueen, M., & Hilgartner, M. W. (1993). Behavioral contracting to improve adherence in patients with thalassemia. Journal of Pediatric Nursing, 8, 106-111.
32. Kravitz, R. L., & Melnikow, J. (2001). Engaging patients in medical decision making. British Medical Journal, 323, 584-585 (Pubitemid 32846119)
33. Kravitz, R. L., & Melnikow, J. (2004). Medical adherence research. Time for a change in direction? Medical Care, 42, 197-199.
34. Krousel-Wood, M., Hyre, A., Muntner, P., & Morisky, D. (2005). Methods to improve medication adherence in patients with hypertension: current status and future directions. Current Opinions in Cardiology, 20, 296-300. (Pubitemid 40896368)
35. Laidlaw, J. K., Beeken, J. E., Whitney, F. W., & Reyes A. A. (1999). Contracting with outpatient hemodialysis patients to improve adherence to treatment. American Nephrology Nurses Association Journal, 26, 37-40.
36. Mann, R. A. (1972). The behavior-therapeutic use of contingency contracting to control an adult behavior problem: weight control. Journal of Applied Behavior Analysis, 5, 99-109.
37. Matas A. J., Humar A., Gillingham K. J., Payne, W. D., Gruessner, R. W., & Kandaswamy, R. et al. (2002) Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney International, 62, 704-714. (Pubitemid 34784617)
38. National Kidney and Urologic Diseases Information Clearinghouse. (2009). The kidneys and how they work. Publication No. 09-3195. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved September 2, 2010 from http://kidney.niddk.nih.gov/Kudiseases/pubs/ yourkidneys/fail.
39. National Kidney Foundation. (2010). How your kidneys work. Retrieved September 2, 2010 from http://www.kidney.org/kidneydisease/howkidneyswrk.cfm.
40. Neale, A. (1991). Behavioral contracting as a tool to help patients achieve better health. Family Practice, 8, 336-342.
41. Pajares, F. (2002). Overview of social cognitive theory and of self-efficacy. Retrieved May 4, 2010 from http://www.emory.edu/EDUCATION/mfp/ eff.html.
42. Piotrowski, N. A., Tusel, D. J., Sees, K. L., Reilly, P. M., Banys, P., & Meek, P., et al. (1999). Contingency contracting with monetary reinforcers for abstinence from multiple drugs in a methadone program. Experimental and Clinical Psychopharmacology, 7, 399-411.
43. Rovelli, M., Palmeri, D., Vossler, E., Bartus, S., Hull, D., & Schweizer, R. (1989a). Noncompliance in renal transplant recipients: evaluation by socioeconomic groups. Transplantation Proceedings, 21, 3979-3981. (Pubitemid 20280465)
44. Rovelli, M., Palmeri, D., Vossler, E., Bartus, S., Hull, D., & Schweizer, R. (1989b). Noncompliance in organ transplant recipients. Transplantation Proceedings, 21, 833-834. (Pubitemid 19118238)
45. Sabaté, E. (2003). Adherence to long-term therapies. Evidence for action. Geneva: World Health Organization.
46. Schweizer, R. T., Rovelli, M., Palmeri, D., Vossler, E., Hull, D., & Bartus, S. (1990). Noncompliance in organ transplant recipients. Transplantation, 49, 374-377. (Pubitemid 20088179)
47. Sims, T. W., & Good, E. W. (2002). The next generation of medications for kidney transplant patients. [Review]. Critical Care Nursing Clinics of North America, 14, 99-109.
48. Wolfe, R. A., Ashby, V. B., Milford, E. L., Akinlolu, O. O., Ettenger, R. E., & Agodoa, L. Y., et al. (1999). Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New England Journal of Medicine, 341, 1725-1730.
49. Wuthrich, R. P., Weinreich T., Ambuhl, P. M., Schwarzkopf, A. K., Candinas, D., & Binswanger, U. (1999). Reduced kidney transplant rejection rate and pharmacoecomonic advantage of mycophenolate mofetil. Nephrology Dialysis Transplantation, 14, 394-399. (Pubitemid 29062797)